The observation of increased expression of IGF-I in the liver in the present work is not in contrast with our previous data reporting that serum levels of IGF-I are inversely associated with the severity of NAFLD. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.